-
Equity Raising Presentation
-
Presentation: Phase 2 study of SNT-5505 in myelofibrosis
-
CEO AGM Presentation to Shareholders
-
Presentation for September Quarterly Shareholder Update
-
Investor presentation
-
Equity Raising Presentation
-
Investor presentation
-
Investor presentation – updated 30 April 2024
-
March 2024 – Presentation for shareholder briefing
-
Investor presentation – NWR Virtual Healthcare Conference
-
Investor presentation – updated 6 March 2024
-
Investor presentation – Euroz Hartleys 2024 Healthcare Forum
-
December 2023 – investor presentation for shareholder briefing
-
Investor presentation – placement and SPP
-
CEO presentation to 2023 AGM
-
Address by chair to 2023 AGM
-
September 2023 – investor presentation for shareholder briefing
-
Investor presentation – Syntara
-
Investor presentation – restructure of Pharmaxis
-
Investor presentation
-
Investor presentation: final MF-101 interim data
-
Investor presentation: PXS-6302 Solaria 2 trial results
-
March 2023 – investor presentation for shareholder briefing
-
Investor presentation
-
December 2022 – investor presentation for shareholder briefing
-
CEO Presentation to 2022 AGM
-
Investor Presentation
-
Investor Presentation
-
Investor Presentation Interim Data from Skin Scarring Study
-
Investor presentation
-
Investor presentation for quarterly shareholder update
-
Investor presentation
-
Investor Presentation
-
R&D Showcase Presentations Webinar 2
-
R&D Showcase Presentations Webinar 1
-
Investor Presentation
-
Presentation – quarterly investor update
-
Investor presentation
-
Investor Presentation
-
Investor Presentation
-
CEO Presentation to 2021 AGM
-
Investor Presentation – September Quarterly Update
-
Investor Presentation
-
Investor Presentation Quarterly Shareholder Update
-
Investor Presentation – 4 June 2021
-
Investor Presentation Capital Raising and Growth Outlook
-
Investor Presentation
